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With this document, we update the recommendations for transoesophageal echocardiography (TOE) of the European Association of Cardio-
vascular Imaging. The document focusses on the areas of interventional TOE, in particular transcatheter aortic, mitral, and left atrial appendage
interventions, as well as on the role of TOE in infective endocarditis, adult congenital heart disease, and aortic disease.
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Introduction
This update of the recommendations for transoesophageal echocar-
diography (TOE) of the European Association of Cardiovascular
Imaging (EACVI) relates to the formerEuropeanAssociationofEcho-
cardiography documents published in 2001 and 2010.1,2 Detailed
guidance concerning indications, instruments, performance, and pre-
cautions can be found there, as well as in similar publications.3 This
new document is intended to provide some additional, updated
recommendations particularly in some fields under rapid evolution,
in particular the use of TOE in the context of catheter-based inter-
ventions, thus not replacing but amending the 2010 document.4
For these interventions TOE data are crucial both in informing man-
agement decisions by the interdisciplinary Heart Team as well as
during or after the procedure. While no fundamental changes in
TOE hardware have occurred since the publication of the previous
documents, the use of 3D-capable transducers has expanded and
software related to 3D data sets continues to evolve, allowing
more complex processing, e.g. measurements of linear dimensions
or curved areas of valvular structures or linking TOE data sets with
simultaneous fluoroscopic images.
In the USA, in 2007 and 2011 appropriate use criteria documents
for echo, including TOE, have been formulated by the pertinent
societies.5,6 These documents are createdbya ‘process [which] com-
binesevidence-basedmedicine andpracticeexperiencebyengaginga
technical panel in a modified Delphi exercise’.5 As such, they consti-
tute expert opinions on good practice which are primarily related to
and geared towards the US-American healthcare system, which
clearly differs in many important ways from other scenarios. Never-
theless, the compilation, evolution, and critical discussion of such cri-
teria can inform non-US-American users of TOE. For example,
reviewing their TOE databases in the light of appropriateness criteria
Bhatia et al.7 found that the most frequent TOE indication ranked as
‘inappropriate’ or overuse was search for endocarditis in patients
with low pre-test likelihood (e.g. transient fever, known alternative
source of infection, or negative blood cultures/atypical pathogen
for endocarditis). On the other hand, it has been pointed out6 that
appropriateness criteria are rarely applied to procedures not per-
formed, thus identifying overuse rather than underuse—
certainly as important a concern as overuse, givencurrent constraints
in health care in large parts of Europe and elsewhere.
Imaging before and during
transcatheter aortic valve
implantation/replacement
Pre-operative TOE
Assessment of aortic valve anatomy and severity of aortic valve
stenosis, together with aortic valve annulus sizing, are crucial in the
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pre-procedural evaluation of candidates for transcatheter aortic
valve implantation (TAVI). Aortic valve anatomy and morphology
should be assessed in detail: bicuspid aortic valve is generally consid-
ered a relative contraindication to TAVI; extensive or asymmetric
calcification, especially of the commissures and of the edge of the
leaflets may result in unfavourable deployment of the valve and com-
plications like paraprosthetic regurgitation and coronary occlusion.
Two-dimensional TOE is the method of choice in evaluating asym-
metry of cusps and bicuspid valve, extent and location of calcification,
and aortic area. Accuratemeasurement of aortic annulus is crucial for
TAVI feasibility and selection of prosthetic size.8– 11 2D transthoracic
echo and TOE are the most frequently used methods to measure the
aortic annulus. However, in patients referred for TAVI, measure-
ments of the aortic annulus using transthoracic echo, TOE, and
cardiac computed tomography (CT) are close but not identical,
and the method used has important clinical implications on the
choice of prosthetic valve size. An annulus diameter by TOE is
obtained in the aortic long-axis at the mid-oesophagus level with
1208 rotation. The ascending aorta should be seen in the long
axis, avoiding tangential cuts. In this view the left or the non-coronary
cusp is seen posteriorly and the right cusp is seenanteriorly.This view
is also commonly used to decide on the ‘landing zone’ during TAVI.
The annular dimension most commonly used in decision-making
for TAVI bisects the annulus at its maximum diameter during early
systole, from the hinge point of the right coronary cusp to the com-
missure between left and non-coronary cusp (Figure1A and B).
However, the aortic annulus may not be circular in all patients, and
a long-axis view may not provide a representative diameter of the
area where the percutaneous valve is intended to be implanted.
Therefore, the use of 3D TOE may provide a more accurate assess-
ment of the aortic valve annular size with better correlation with CT
measurements.12,13 This is achieved by visualizing a short-axis view of
the aortic annulus, defined as a virtual ring formed by joining the basal
attachments of the aortic leaflets (Figure 2). In this short-axis view,
the maximum diameter, the minimum diameter, and the area of
aortic annulus are measured in systole. Several studies demonstrated
that aortic annulus measurements by TOE showed a slight
underestimation in comparison with CT (more pronounced with
2D TOE than with 3D TOE). To date, most of the series have pro-
vided good results by using 2D echo for aortic annulus sizing;
however, CT or 3D TOE-guided prosthesis sizing leads to implant-
ation of larger prostheses than if guided by 2D TOE or 2D transthor-
acic echo, reinforcing the importance of a 3D assessment of the
annulus.14 Moreover, the distance from the left main coronary
ostium to the aortic annulus pre-operatively and to the aortic pros-
thesis post-operatively can be assessed by 3D TOE.15
TOE for guidance of the procedure
Several steps of the procedure may be guided by TOE: the aortic
valve crossing, balloon dilatation, and positioning and deployment
of the prosthesis (Figure 3). However, the need for patient sedation
in order to tolerate the TOE probe has led to most institutions per-
forming this procedure under fluoroscopy only. Nevertheless, TOE
can help to monitor catheter and prosthesis positioning as well as
evaluate results and complications. Immediately after valve deploy-
ment, prosthetic valve stent position, shape, leaflet motion, and
aortic regurgitation should be rapidly assessed with TOE. Differ-
ences in monitoring and imaging the procedure are due to main
characteristics of the two types of prostheses most commonly
implanted: the shorter, balloon-expanded Edwards Sapien pros-
thesis (Edwards Life Science), which is anchored at the annulus
and extends to a level below the sino-tubular junction, and the
longer self-expandable Core Valve (Medtronic), which extends
from the annulus into the proximal ascending aorta. The optimal
positioning of the Edwards Sapien prosthesis is with the ventricular
side of the prosthesis positioned 2–4 mm below the annulus in the
left ventricular outflow tract (without interfering with the mitral
leaflets). For the CoreValve, the ventricular edge of the prosthesis
should be placed 5–10 mm below the aortic annular plane. It is
important to confirm that all the prosthetic cusps are moving
well, that the valve stent has assumed a circular configuration
(using 2D or 3D views), and that there is no significant transpros-
thetic or paraprosthetic regurgitation. Some (generally mild) regur-
gitation through the prosthesis is common while the delivery
Figure 1 (A) Long-axis TOE view showing the left ventricular outflow tract (LVOT), aortic root (Ao), and left atrium (LA). (B) Same view as (A),
showing the measurement of the annulus: from the hinge point of the right coronary cusp to the left-non-coronary commissure.
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Figure2 Stepwise approach to measuring the aortic annulus area from transoesophageal 3D echocardiographic data. In the composite figure, the
‘classic’ long-axis view (LAX) of the aortic valve and ascending aorta, as typically acquired around 1208, is to the left, the perpendicular long-axis
(LAX) view of the aortic valve and ascending aorta in the middle (this plane is not part of the 2D examination), and the short-axis view (SAX), as
typically acquired around 308, is displayed to the right. This SAX view, however, is oriented as if looking from the left ventricular outflow tract
and thus a mirror image of the typical 2D TOE SAX view. N, R, and L denote the three cusps, with N/L or R/L where the cusp identity may vary
individually. Row (A): initial orientation of the three planes, which are perpendicular to each other and all centred on the centre of the aortic
valve. Row (B): adjustment of the SAX such that the line controlling the SAX view is aligned (arrows) to the lowermost cusp attachments
(‘nadirs’) visible in the two LAX views. The SAX should now be roughly in the correct position, containing the three nadirs of the cusp attachments.
Row(C): tocheck thecorrectpositionof theSAX, theclassic and theperpendicular LAX viewsarerotated around their central commonaxis (curved
arrow) in order to fine-tune the SAX view position making sure that the lowermost attachment point (‘nadir’) of each cusp has been identified in the
left and middle planes and incorporated into the SAX view. Row (D): after a rotation by 908, the classic LAX becomes the perpendicular LAX and vice
versa. Row (E): further rotation of the LAX views generates views that are rotated around the long axis by 1808 from their position in C and 908 from
their position in D. During the rotation from C to D and from D to E the lowermost point of attachment (nadir) of each cusp is checked and the SAX
corrected accordingly. In the right picture, the contour of the aortic annulus is inscribed as an idealized ellipse to clarify that the annulus is non-
circular.
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apparatus and/or guidewire remains across the valve and may
persist, to a lesser degree, after their removal. Besides the visualiza-
tion of all anatomic and functional details in the mid-oesophagus
long- and short-axis views, a transgastric TOE examination including
continuous-wave, pulsed-wave, and colour Doppler should be used
to confirm satisfactory prosthetic functioning before the probe is
finally removed. This window is essential to ensure that all regurgi-
tant jets are detected and allow measurements of peak and mean
prosthetic gradients.
Incomplete expansion or incorrect positioning of the device, or in-
appropriate prosthetic size may cause significant paraprosthetic re-
gurgitation (Figure 4). Assessment of severity of paraprosthetic and
transprosthetic aortic regurgitation follows the approach for native
valves, but distinguishing moderate and severe regurgitation is
often difficult. A rough rule for paraprosthetic regurgitation is that
a regurgitation orifice comprising .20% of the circumference
(.728) in a short-axis view most likely represents severe regurgita-
tion.16 3D TOE is an additional tool to define the severity and precise
location of paraprosthetic and/or central regurgitation. Significant re-
gurgitation may be an indication for repeat balloon inflation to
attempt a maximal expansion of the valve (or in the case of failure
to implant a second device).
TOE in evaluating procedural
complications
Severe hypotension, cardiac arrhythmias, and acute ECG changes
may occur during all phases of the procedure and TOE can immedi-
ately identify potential complications. Indeed, cardiac tamponade
secondary to wire perforation of the left or right ventricle, left ven-
tricular dysfunction, severe aortic regurgitation, or new or increased
mitral regurgitation can be immediately diagnosed by TOE. Occlu-
sion of the coronary ostia may occur by fragment embolization or
by an obstructive portion of the valve frame, sealing cuff, or native
cusp. This life-threatening complication may be promptly diagnosed
with TOE which shows the disappearance of diastolic left main cor-
onary artery flow and new left ventricular dysfunction. 3D TOE may
also directly visualize the distance of the left main coronary ostium to
the implanted valve showing whether the prosthesis reaches or over-
laps the coronary ostium (15; Figure 5). Rarely, a tear or rupture of the
aortic root may be observed during the procedure after balloon val-
vuloplastyor prosthesisdeployment, especially in the presence of ex-
tensive annular calcification or prosthesis oversizing. Possible
sources of peri-interventional ischaemic stroke detectable by TOE
are aortic cusp fragment embolization, atheroembolism, thrombo-
Figure 3 Monitoring TAVI. (A) Passage of the catheter across the aortic valve; (B) ballooning of the valve (arrow); see also Supplementary data
online, SupplVideoValvuloplasty. (C) Deployment of the prosthesis (arrow); see also Supplementary dataonline, SupplVideoTAVIdeployment. (D) A
long-axis view of the implanted valve (arrow); (E) A 3D short-axis view of the implanted valve; (F) a deep transgastric view showing the Doppler
gradient of the implanted prosthesis. LA, left atrium; Ao, proximal aorta.
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embolism from catheters, air embolism, or aortic arch dissection
extending into the supra-aortic vessels.
Transoesophageal imaging in
percutaneous mitral valve
edge-to-edge repair
Percutaneous mitral valve repair has evolved into a therapeutic
option for high surgical risk or inoperable patients with severe
mitral regurgitation.17,18 Both functional regurgitationand valvular in-
sufficiency due to prolapse and flail leaflet are amenable to interven-
tional treatment. Two strategies have been developed for the
interventional therapy of mitral regurgitation:
(i) The edge-to-edge adherence of anterior and posterior mitral
leaflet tips using aclip at the site of the regurgitation (preferential-
ly segments A2/P2), which is similar to the surgical technique
described by Alfieri. The clip anchors the prolapsed leaflet or
flail in the case of degenerative mitral regurgitation, while it
improves coaptation of the tethered leaflets in the case of func-
tional regurgitation. In addition, the tissue bridge created by the
clip may reduce annular dilatation.
(ii) Direct and indirect mitral annuloplasty, with indirect annulo-
plasty using a device implanted into the coronary sinus. This tech-
nique, however, has not found wide acceptance in clinical
practice due to the limited effectiveness, and echocardiographic
guidance will therefore not be discussed.
In mitral edge-to-edge repair, which has been performeduntil 2013 in
9000 patients, TOE has critical importance in three areas:
Pre-interventional evaluation
The indication to perform the edge-to-edge procedure has to con-
sider patient symptoms, valvular morphology and mechanism of
regurgitation, severity of mitral regurgitation, and other cardiac
pathology. Mitral clipping can be used for functional mitral regurgi-
tation as well as prolapse and flail leaflet. After confirming the
presence of moderate-to-severe or severe mitral regurgitation
according to current guidelines,19 it is critical to assess the mitral
valve morphology by several parameters in order to assess the like-
lihood of procedural success. These parameters (Table 1, Figure 6)
are mostly derived from the clinical trials such as the Everest II
study.18 In functional regurgitation, coaptation length and depth
have to be defined from a four-chamber view. The coaptation
length has to be ≥2 mm and a coaptation depth of ,11 mm. In
flail mitral valves, the flail gap, which is the distance separating the
flail segment from its opposing normally coapting leaflet, should be
,10 mm to facilitate leaflet grasping. In addition, the flail/prolapse
width should be ,15 mm. Characteristics such as significant calcifi-
cation of a leaflet at the site of grasping, short (,8 mm length) and
very restrictive posterior leaflets, and mitral valve opening area
,4 cm2 or mean pressure gradient at rest .4 mmHg should result
in exclusion of the patient. It is optimal to have the pathology in seg-
ments A2/P2, while pathology in segments 1 and 3 is less optimal for
treatment.
Figure4 Paraprosthetic regurgitation. (A) Regurgitant jet due to a paraprosthetic leak detected in the long-axis view; see also Supplementary data
online, SupplVideoParaprosthReg. (B) Corresponding short-axis view. (C) 3D clearly defines the morphology and dimension of the leak (arrow).
(D) Moderate-to-severe transprosthetic regurgitation; note proximal convergence zone indicating central origin of jet. See also Supplementary
data online, SupplVideoTransprosthReg. LA, left atrium; Ao, proximal aorta.
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Echocardiographic guidance of the
interventional procedure
Echocardiography has superior importance compared with fluoros-
copy in the guidance of the mitral clipping procedure as well as the
assessment of the procedural result, and should therefore be part
of every such procedure.20 Essential steps of the procedure which
are guided by TOE are the transseptal puncture, the advancement
of the dilator through the interatrial septum, the navigation of the
clip-delivery-system in the left atrium towards the mitral valve, the
positioning of the clip above the regurgitant area of the mitral
valve, the adjustment of perpendicularityof the clip to the mitral valve
intercommissural line, the advancement of the clip into the left ven-
tricle, the grasping of anterior and posterior leaflet by the clip while
pulling the clip back from the left ventricle towards the left atrium,
and finally the closure of the clip. The transseptal puncture should
be at a superior–posterior position 3.5–4 cm above the leaflets to
facilitate positioning of the clip. This is controlled by a bicaval view
(115–130o) and a short-axis view (30–60o). Subsequent positioning
of the clip-delivery system above the mitral valve is controlled by an
intercommissural view (55–75o) to adjust the medial– lateral align-
ment and a left ventricular outflow tract view (120–150o) to adjust
the posterior–anterior alignment. 3D TOE allows for improved
spatial orientation compared with 2D TOE in particular in this step
as well as the subsequent alignment of the opened clip perpendicular
to the coaptation line21,22, (Figure 7; see also Supplementary data
online, videos). If 3D TOE is not available, a transgastric short-axis
view should be used to confirm the perpendicularity of the opened
clip above the mitral valve as well as to reconfirm it after entrance
into the left ventricle. Simultaneous grasping of the anterior and pos-
terior leaflet must be confirmed in the left ventricular outflow tract
view. A long loop should be stored to allow reviewing of this critical
step and potential correction to avoid later detachment of one leaflet
from the clip. Before the clip is released, good grasping of the anterior
and posterior leaflet has to be assured; zoom images are helpful in this
regard. Intercommissural views will allowadditional analysis whether
the leaflets take course into the closed clip. 3D TOE may also be used
to demonstrate the resultant tissue bridge.
After the clip has seized the anterior and posterior leaflet, one
lateral and one medial (septal) opening are created, replacing the
largernative mitral valve opening. Adequate reduction of the mitral re-
gurgitation has to be confirmed by colour Doppler, and a relevant
mitral stenosis needs to be excluded. To evaluate the severity of the
remaining mitral regurgitation in the complex double-orifice situation,
2D as well as 3D colour Doppler techniques should be applied.23 In
case sufficient reduction of the regurgitation severity cannot be
achieved using one clip only in spite of repeated grasping for optimiza-
tion, further clips may be used to achieve greater reduction of the re-
gurgitation.Duetothemultiplecomplex interventional steps requiring
Figure5 Example of a 3D TOE post-interventional evaluation of the aortic root and prosthesis in orthogonal views. (A) A short-axis view of aortic
root at the level of the aortic prosthesis and the left main coronary; (B) a longitudinal view of the ascending aorta showing the aortic prosthesis length
and the overlap of the prosthesis with the anterior mitral valve leaflet; (C) a longitudinal view of the ascending aorta with the take-off of the left main;
this view allows the measurement of the distance between the upper edge of the prosthesis and the left main. (D) An en-face 3D view of the left main
ostium and prosthesis upper edge. LA, left atrium; Ao, proximal aorta; LM, left main coronary ostium.
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different guiding views, the procedure requires optimal coordination
between expert echocardiographers and interventionalists.
While the interventional edge-to-edge repair is a relatively safe
procedure, pericardial effusion due to perforation of the atrial wall,
detachment of the clip from the mitral valve after initial seating, as
well as destruction of the mitral leaflets due to multiple grasping pro-
cedures or chordal rupture are potential complications. All of these
complications can be easily detected by TOE.
Post-interventional evaluation
Echocardiographic follow-up studies should be performed to deter-
minemitral regurgitation severityas well as left ventricular function.A
follow-up TOE allows improved understanding of the morphological
causes of recurrent significant mitral regurgitation.
TOE in left atrial appendage
device closure
TOE is used for pre-procedural evaluation of the left atrial append-
age, for guidance of the procedure and for follow-up studies.
† Pre-procedural evaluation. To define the presence of clots within
the left atrial appendage, determine the sizeof its orifice, the sizeof
the landing zone, the depth of the left atrial appendage, and the
number of lobes. Sizing is done in multiple views allowing short-
and long-axes analysis, and 3D TOE may be advantageous.
†Guidance of the procedure. TOE is integral part of the procedure
for the following steps: transseptal puncture, analysis of multiple
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Recommended criteria for echocardiographic
analysis of the mitral valve prior to percutaneous
edge-to-edge repair
Criteria Assessment
Mitral leaflet coaptation length ≥2 mm length
recommended
Mitral leaflet coaptation depth ,11 mm depth
recommended
Gap between leaflet in case of
flail leaflet
,10 mm gap recommended
Width of flail leaflet area ,15 mm width
recommended
Mitral valve opening area .4 cm2 area recommended
Leaflet thickness ≤5 mm thickness
recommended
Considerable calcification of the
mitral annulus
Should not be present
Marked valvular cleft or leaflet
perforation
Should not be present
Marked restriction of posterior
leaflet
Should not be present
Lack of primary or secondary
chordae support
Should not be present
Calcification of the leaflets in the
grasping area
Should not be present
Several significant regurgitant jets Should not be present
Figure 6 Parameters to describe mitral valve morphology in functional (FMR) and degenerative (DMR) mitral regurgitation.
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signs of adequate device position before device release, detection
of complications such as pericardial effusion, mitral valve impinge-
ment, or obstruction of the left upper pulmonary vein.
† Follow-up studies. Confirmation of adequate device position,
of complete occlusion of the left atrial appendage orifice
without flow inside the appendage, and exclusion of thrombus
adherent to the device (see Figure 8 and Supplementary data
online, clip).
TOE in infective endocarditis
TOE gives useful information concerning the diagnosis of infective
endocarditis, theassessmentof the severityof the disease, thepredic-
tion of short-term and long-term prognosis, and the follow-up of
patients under specific antibiotic therapy. Transthoracic echo must
be performed first in all cases, because it is a non-invasive technique
giving useful information both for the diagnosis and the assessment
of severity of infective endocarditis. TOE needs to be performed in
the majority of patients with suspected infective endocarditis,
because of its better image quality and better sensitivity, except in
the case of good quality negative transthoracic echocardiography
associated with a low level of clinical suspicion.24
Anatomically, infective endocarditis is characterized by a combin-
ation of vegetations and destructive lesions:25
(i) A vegetation presents as an oscillating mass attached to a val-
vular structure, with a motion independent of that of the
valve, but may also present as non-oscillating mass with atypical
Figure8 Simultaneous biplane view of short- and long axis of the left atrial appendage showing the occluder in place (arrow). The device consists
of a body placed within the appendage and a cap at the orifice of the appendage. LA, left atrium, LAA, left atrial appendage. See also Supplementary
data online, SupplVideoLAAoccluder. See legend for Figure 8.
Figure 7 A 3D TOE image acquired in the zoom mode from the
left atrium showing the open clip in central position above the mitral
valve and perpendicular to the intercommissural line. A, anterior; L,
lateral; M, medial; P, posterior (inferolateral). See also Supplemen-
tary data online, SupplVideo2DTOEbeforeclipping: 2D TOE
showing both arms of the opened clip just above the mitral valve.
Supplementary data online, SupplVideo3DTOEbeforeclipping: 3D
TOE showing the open clip just above the mitral valve. The clip dir-
ection is perpendicular to the closure line of the mitral leaflets. See
Supplementary data online, SupplVideo3DTOEafterclipping. This
shows the clip-delivery system in the left atrium as well as the anter-
ior and posterior mitral leaflet with a tissue bridge due to the closed
clip. There is an opening medial and lateral to the tissue bridge.
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location. Transthoracic echo has a sensitivity of 75% for the
diagnosis of vegetations, which may be increased to 85–90%
by performing TOE. However, the sensitivity of TOE is
reduced in prosthetic valves and in infective endocarditis affect-
ing intracardiac devices.
(ii) An abscess typically presents as a perivalvular zone of reduced
echo density, without colour flow detected inside, and may be
complicated by pseudoaneurysm and fistula (Figure 9). The sen-
sitivity of TOE for the diagnosis of abscess is 90% with high
additional value when compared with transthoracic echo.
(iii) Other destructive lesions may include valve aneurysm, perfor-
ation, or prolapse, and chordal or less frequently papillary
muscle rupture. The main consequences of these lesions are
severe valve regurgitation and heart failure. TOE is of major
value for their assessment.
In addition, both transthoracic echo and TOE are useful for the as-
sessment of the underlying valve disease and for the assessment of
consequences of infective endocarditis, including left ventricular
size and function, quantification of valve regurgitation/obstruction,
assessment of right ventricular function, and of pulmonary pressures.
Other important points to keep in mind regarding the role of TOE in
infective endocarditis are the following:
(i) the diagnosis of infective endocarditis remains difficult in some
situations (pacemaker, prosthetic valves); a negative TOE never
completely rules out infective endocarditis;
(ii) TOE must be repeated in the case of persistent clinical suspicion
of infective endocarditis26
(iii) 3D echocardiography is useful for correct description of the
lesions, particularly in cases of valve perforation and abscess
(Figure 10 and Supplementary data online, clip)
(iv) transthoracic echo and TOE are complementary and both must
be performed in the majority of patients.
Adult congenital heart disease
Currently, TOE is less frequently utilized to evaluate adults with con-
genital heart disease (CHD) due to an increasing role of CT and car-
diovascular magnetic resonance in demonstrating both cardiac and
vascular congenital anomalies. Diagnostic advantages of the two mo-
dalities over echocardiography in this area are specified in the corre-
sponding guidelines.27 Since inadequate or equivocal transthoracic
echo is the main indication for selecting TOE, cardiovascular magnet-
ic resonance, or CT, one has to realize relative merits and limitations
of these three imaging techniques while planning an optimal non-
invasive diagnostic algorithm for an individual patient in a given clinical
scenario. The advantages of TOE involve high spatial and temporal
resolution enabling excellent evaluation of thin and mobile struc-
tures, no radiation, no need for ionic contrast injection, repeatability
and portability. Extensive experience in echocardiography in evaluat-
ing adult CHD, transoesophageal probe introduction and manipula-
tion, and acquisition of relevant images are prerequisites of a
complete diagnostic TOE study.
Prior to every examination one should be fully aware of:
(i) Clinical indications for the study (questions to be answered to
offer a best therapeutic option).
(ii) Conclusions and uncertainties still existing after a complete
transthoracic echocardiography.
(iii) Course of the disease, current clinical data, in particular the
presence of arrhythmia and degree of desaturation in cyanotic
patients.
Figure9 Perivalvular lesions in infective endocarditis: role of TOE: (A) abscess: thickened non-homogeneous perivalvular areawith echodense or
echolucent aspect. (B) Pseudo-aneurysm: pulsatile perivalvular echo-free space with flow detected on colour Doppler. (C) Mitral aneurysm with
anterior mitral valve perforation into the left atrium. LA, left atrium; LV, left ventricle; Ao, aorta.
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(iv) In patients after either surgical or percutaneous intervention:
clinical diagnosis prior to the intervention, nature of the inter-
vention/operation, cardiac morphology and function prior to
and after the intervention, complications during and after a pro-
cedure, and follow-up.
TOE can be hampered or entirely precluded by several factors. Con-
genital or acquired oesophageal and/or bronchial disease, oropha-
ryngeal pathology, and cervical injuries or anomalies leading to
restricted neck mobility may interfere with probe introduction and
tip manipulation. Therefore, a history of former oesophageal intuba-
tions should be obtained. In cyanotic patients, non-invasive monitor-
ing of saturation (pulse oximetry) is advised. Particular care should be
exercised in patients with severe pulmonary hypertension, in whom
saturation should be monitored and blood pressure spikes during the
examination should be avoided.
The extent of required TOE imaging depends on the clinical
indication (Table 2). If a study is not primarily focused on a well-
defined problem, such as the evaluation of atrial septal defect morph-
ology or valvular function, TOE should provide complete informa-
tion concerning cardiac anatomy based on a segmental approach
similarly to transthoracic echo (Table 3). Studying adult CHD
requires the use of all standard imaging planes andDoppler interroga-
tions. Particular utility of transgastric planes in these patients should
be emphasized, especially to estimate pressure gradients across both
outflow tracts or left ventricular cardiac output by Doppler.28,29 Al-
thoughall TOEplanes can berelativelyeasilyobtained inpatientswith
normal position of the heart within the chest (levocardia), this may be
challenging in the case of mesocardia or dextrocardia. In the latter
two, obtaining diagnostic images is usually difficult, requires non-
standard planes adjusted to a given patient, and may be less rewarding
or, in the case of dextrocardia, even not possible.
The most common indication for TOE in CHD is to evaluate an
interatrial communication. In this case, the aim is to define atrial
septal defect type (secundum, primum, superior/inferior vena cava,
sinus coronarius), presence, and characteristics of patent foramen
ovale and to establish shunt direction. The description of secundum
atrial septal defect or patent foramen ovale should include the suit-
ability for percutaneous closure. This includes the largest defect
diameter, extent of tissue rims enabling successful device deploy-
ment, possible other defects missed during transthoracic echo,
tissue strands crossing the defect precluding device placement, ex-
tensive Eustachian valve and Chiari network, as well as concomitant
pulmonary venous anomalies. The rim characterization is of para-
mount importance. Rim segments may be named after the respective
adjacent structures (superior vena cava, aorta, coronary sinus, infer-
ior vena cava) or specified as a superior, anterosuperior, anteroin-
ferior, inferior, and posterior (inferolateral). A rim width ,5 mm
(except at the aortic side of the defect) is generally regarded to
preclude device closure. 3D TOE offers improved spatial orientation
and substantial information gain with respect to the evaluation
of various forms of interatrial septal pathologies,30,31 especially by
offering en-face views of the septum and the defect. The presence
of a shunt is proved by colour Doppler and/or contrast injection.
Sinus venosus atrial septal defects of both superior and inferior
vena cava types are rare forms of the defects, which are demon-
strated by TOE with great accuracy. In these pathologies, TOE also
allows to demonstrate partial abnormal drainage of right upper/
lower pulmonary vein into the superior/inferior caval vein, respect-
ively, invariably coexisting with these septal defects. Primum atrial
septal defect (partial atrio-ventricular septal defect) does usually
Figure 10 3D TOE in infective endocarditis: (A) Large mitral vegetation (arrow): 3D TOE atrial view. See also Supplementary data online,
SupplVideoIEmitralvegetation. (B) Anterior mitral valve perforation (arrow) 3D TOE atrial view. See also Supplementary data online, SupplVideoIE-
PerforationAML. (C) Perforation of the non-coronary aortic leaflet: 3D TOE. See also Supplementary data online, SupplVideoIEPerforationaortic-
cusp. LV, left ventricle; Ao, aorta; AML, anterior mitral leaflet; PML, posterior mitral leaflet.
Table 2 Indications for TOE in patients with CHD
(modified after ref. 41)
1. Diagnostic indications
(a) Non-diagnostic transthoracic echocardiography in suspected
CHD
(b) Evaluation of intracardiac or extracardiac baffles following the
Fontan, Senning or Mustard procedure
(c) Other general indications, not characteristic only of CHD
(infective endocarditis, prosthetic valve function, prior
cardioversion, etc.)
2. Perioperative indications
3. TOE-guided interventions (e.g. atrial septal defect closure)
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not require TOE unless coexisting atrio-ventricular valve pathology
needs complete evaluation of morphology and function prior to
and after the repair. In some of these patients, a double-orifice
left atrio-ventricular valve can be demonstrated. Occasionally,
there may be a double-orifice right atrio-ventricular valve.28
Another common indication concerns the evaluation of the left
ventricular outflow tract in order to demonstrate the exact morph-
ology (e.g. a membrane) and degree of the obstruction.29
Occasionally, 3D TOE may offer a better insight into the anatomy
of such obstruction.32
TOE in aortic diseases
The role of TOE in aortic diseases has changed in recent years.
Although TOE is one of the techniques of choice for diagnosing thor-
acic of aortic diseases, transthoracic echo combined with CT is more
often the primary strategy in the emergency setting and follow-up of
aortic diseases. However, TOE does play a crucial role in the pre-
operative, intra-operative, and post-operative control of surgically
treated aortic diseases.
Aortic dissection
TOE has been considered a first-line imaging modality in the diag-
nosis of aortic dissection, mainly in patients with haemodynamic
compromise.33,34 However, TOE is limited in visualizing the
distal part of the ascending aorta and abdominal aorta and tends
to be observer- and experience dependent. When the diagnosis
of type A dissection is clearly established by CT or transthoracic
echocardiography, confirmatory TOE does not seem justified.33
TOE is better than non-gated CT for location of the entry
tear,35 identification of aortic regurgitation mechanisms, and as-
sessment of false lumen flow.33 Recent reports have highlighted
the diagnostic benefit of echo contrast to TOE.36,37 This may be
helpful to
(i) clarify artefacts by intraluminal reverberations,
(ii) detect entry tears not identified without contrast by showing
early arrival of contrast into the false lumen (Figure 11, see
also Supplementary data online, clip),
(iii) identify retrograde or antegrade flow in the false lumen
(iv) distinguish the true and false lumen in cases where systolic
expansion of the true lumen is not clear cut.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Segmental evaluation of heart anatomy and
function in congenital heart disease
Anatomical segment/
connection
Example of pathology
Atrial morphology and
arrangement
Situs inversus
Left/right atrial isomerism
Juxtaposition of atrial appendages
Cor triatriatum
Pulmonary or systemic
venous connection
Complete/partial abnormal pulmonary
venous connection, persistent left
superior caval vein with or without
absent right superior caval vein,
pulmonary or systemic vein stenosis
Interatrial septum Atrial septal defect
Patent foramen ovale
Aneurysm
Pouch
Atrio-ventricular
connection and relation
Atrio-ventricular discordance
(ventricular inversion)
Double inlet
Criss-cross heart
Supero-inferior ventricles
Atrio-ventricular valves Cleft
Double orifice
Additional valve tissue
Parachute mitral valve
Hypoplasia
Dysplasia
Stenosis
Atresia
Straddling
Overriding
Ebstein anomaly
Interventricular septum Ventricular septal defect
Ventricular outflow tract Left—tunnel, discrete subvalvular
obstruction
Right—double-chambered right
ventricle
Ventriculo-arterial
connection
Transposition
Double outlet
Common arterial trunk
Great arteries Valvular pathology
Supravalvular obstruction
Patent arterial duct
Aortopulmonary window
Major aortopulmonary collateral
arteries (MAPCAS)
Coronary arteries Abnormal origin, fistulas
Figure 11 Type B dissection. Contrast-enhanced TOE of the
descending aorta in Type B aortic dissection. Antegrade contrast
flow is observed in true lumen (large arrow). Absence of significant
flow in the false lumen. Small arrows show contrast-enhanced flow
fromthe true lumen to the false lumen throughsecondary tears. See
also Supplementary data online, SupplVideoAodescContrast.
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Ideally, TOE should be performed immediately before surgery or
endovascular treatment, in the operating theatre and under general
anaesthesia. Particular strengths of TOE are assessment of coronary
ostial involvement in Type A dissection, assessment of cannulae pos-
ition, perfusion of different segments and compartments of the aorta
(e.g. whether the true lumen is being perfused), and severity of re-
sidual aortic regurgitation, as well as detection of complications,
such as pseudoaneurysm formation, most of which are secondary
to a leak from coronary artery reimplantation to the graft tube, or
communication of the distal part of the tube to the false lumen. Simi-
larly, intra-operative TOE is highly useful during endovascular treat-
ment in complicated descending aorta dissections. It permits correct
guidewire entrance by identifying the true lumen in aortic dissections,
provides additional information helpful to guide correct stent-graft
positioning, and identifies suboptimal results and the presence of
leaks and/or small re-entry tears, with much higher sensitivity than
angiography.
Antegrade or retrograde false lumen flow, false lumen thrombosis,
and the presence of communications have prognostic implications
and are easily detected by TOE. In patients with residual patent
false lumen in the descending aorta, the presence of a large proximal
entry tear (.10 mm) defined by TOE has a high risk of mortality
and indicates the need for surgical or endovascular treatment
during the follow-up (see also Supplementary data online, clip
SupplVideoIntimaltea, showing a 3D en face view of the intimal tear
in aortic dissection; 35).
Aortic aneurysm
Intra-operative TOE should be used routinely in thoracic aortic
surgery. Ascending aorta dimensions, aortic regurgitation severity,
and its mechanisms enable pre-operative selection of the best surgi-
cal strategy and preparation of an adequately sized graft tube, repair,
or replacement of the aortic valve, and shorten surgical ischaemia
time.38,39 Further, TOE provides highly accurate information on the
functional anatomy of aortic regurgitation which is strongly and inde-
pendently predictive of valve repairability and post-operative
outcome.40
Supplementary data
Supplementary data are available at European Heart Journal – Cardio-
vascular Imaging online.
Conflicts of interest: none declared.
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A 47-year-old woman with a past history of left chor-
oidal malignant melanoma submitted to eye enucle-
ation 13 years before presented to the emergency
department because of pleuritic chest pain, shortness
of breath, and tiredness.
Transthoracic echocardiography revealed pericar-
dial thickening and multiple confluent hypoechoic
nodular images, extending into the adjacent myocar-
dium (Panel A, arrow, Supplementary data online, Clip
S1). For tissue characterization, a cardiac magnetic res-
onance was performed, confirming diffuse pericardial
thickening and multiple myocardial masses with
heterogeneous behaviour and hyperintense sign in T1- and T2-weighted sequences, respectively, positive for perfusion and with areas of
delayed enhancement along the masses and within the whole pericardium (Panels B–E, Supplementary data online, Clip S2–S5). These
findings were compatible with the myopericardium malignant tumour involvement. A fluoro-D-glucose positron emission tomography
scan excluded extracardiac tumour extension/focuses (Panel G). Conventional histology (Panel F, haematoxylin/eosin) and immunohisto-
chemistry, positive for neural crest derived markers HMB-45 and S-100-protein, confirmed malignant melanoma metastasis on cardiac
needle biopsy. The patient was put on dacarbazine chemotherapy with symptomatic relieve at a 6-month follow-up period.
Advanced metastatic malignant melanoma has a very high propensity for heart metastization, being noted in a significant number of
patients at autopsy. Nevertheless, exclusive and symptomatic cardiac extension with main pericardial affection-related complains is
rare, namely for primary eye tumours.
Supplementary data are available at European Heart Journal – Cardiovascular Imaging online.
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